ExamWorks Group (NYSE: EXAM ) reported earnings on July 30. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), ExamWorks Group beat expectations on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly. Non-GAAP loss per share didn't move. GAAP loss per share contracted.
Margins grew across the board.
ExamWorks Group reported revenue of $156.1 million. The three analysts polled by S&P Capital IQ expected to see net sales of $151.6 million on the same basis. GAAP reported sales were 22% higher than the prior-year quarter's $127.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.10. The three earnings estimates compiled by S&P Capital IQ anticipated -$0.10 per share. Non-GAAP EPS of -$0.10 were the same as the prior-year quarter. GAAP EPS were -$0.08 for Q2 compared to -$0.10 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 34.6%, 50 basis points better than the prior-year quarter. Operating margin was 2.6%, 120 basis points better than the prior-year quarter. Net margin was -1.8%, 80 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $152.9 million. On the bottom line, the average EPS estimate is -$0.07.
Next year's average estimate for revenue is $607.2 million. The average EPS estimate is -$0.32.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 20 members out of 33 rating the stock outperform, and 13 members rating it underperform. Among 11 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), six give ExamWorks Group a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on ExamWorks Group is outperform, with an average price target of $20.75.
Is ExamWorks Group the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add ExamWorks Group to My Watchlist.